The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection

被引:43
|
作者
Lefrère, JJ
Roudot-Thoraval, F
Mariotti, M
Thauvin, M
Lerable, J
Salpétrier, J
Morand-Joubert, L
机构
[1] Hop St Antoine, Inst Natl Transfus Sanguine, Virol Lab, F-75571 Paris, France
[2] Hop Henri Mondor, Dept Sante Publ, F-94010 Creteil, France
来源
JOURNAL OF INFECTIOUS DISEASES | 1998年 / 177卷 / 06期
关键词
D O I
10.1086/515308
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cohort of 103 human immunodeficiency virus type 1 (HIV-l)-infected persons with well-defined dates of seroconversion were studied to determine whether baseline plasma HIV RNA loads 6-12 months after seroconversion have prognostic value. Baseline plasma virus loads had predictive value for the disease-free survival rate and for the survival rate. The level of baseline HIV RNA also had a strong negative predictive value for the CD4(+) T cell count during the fifth year of infection: A baseline load >5 log was predictive of a CD4(+) T cell count <500/mm(3) 5 years after infection. Baseline HIV RNA load was a CD4(+) T cell-independent predictor of progression to death. The major finding was that the disease outcome for HIV-l-infected persons is already determined during the first year of infection.
引用
收藏
页码:1541 / 1548
页数:8
相关论文
共 50 条
  • [1] Rapid progression to human immunodeficiency virus type 1 disease
    Robinson, NJ
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06): : 1526 - 1526
  • [2] Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression
    Sagar, M
    Lavreys, L
    Baeten, JM
    Richardson, BA
    Mandaliya, K
    Chohan, BH
    Kreiss, JK
    Overbaugh, J
    JOURNAL OF VIROLOGY, 2003, 77 (23) : 12921 - 12926
  • [3] CYTOMEGALOVIRUS AS A COFACTOR OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    NARDIELLO, S
    DIGILIO, L
    PIZZELLA, T
    GALANTI, B
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1994, 24 (02): : 86 - 89
  • [4] NEOPTERIN AS A PREDICTIVE MARKER FOR DISEASE PROGRESSION IN HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION
    FUCHS, D
    SPIRA, TJ
    HAUSEN, A
    REIBNEGGER, G
    WERNER, ER
    FELMAYER, GW
    WACHTER, H
    CLINICAL CHEMISTRY, 1989, 35 (08) : 1746 - 1749
  • [5] Human immunodeficiency virus type 1 subtypes differ in disease progression
    Kanki, PJ
    Hamel, DJ
    Sankalé, JL
    Hsieh, CC
    Thior, I
    Barin, F
    Woodcock, SA
    Guèye-Ndiaye, A
    Zhang, E
    Montano, M
    Siby, T
    Marlink, R
    NDoye, I
    Essex, ME
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01): : 68 - 73
  • [6] Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression
    Troyer, RM
    Collins, KR
    Abraha, A
    Fraundorf, E
    Moore, DM
    Krizan, RW
    Toossi, Z
    Colebunders, RL
    Jensen, MA
    Mullins, JI
    Vanham, G
    Arts, EJ
    JOURNAL OF VIROLOGY, 2005, 79 (14) : 9006 - 9018
  • [7] Status of selected nutrients and progression of human immunodeficiency virus type 1 infection
    Bogden, JD
    Kemp, FW
    Han, SG
    Li, WJ
    Bruening, K
    Denny, T
    Oleske, JM
    Lloyd, J
    Baker, H
    Perez, G
    Kloser, P
    Skurnick, J
    Louria, DB
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 72 (03): : 809 - 815
  • [8] Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection
    Thobakgale, Christina F.
    Prendergast, Andrew
    Crawford, Hayley
    Mkhwanazi, Nompumelelo
    Ramduth, Danni
    Reddy, Sharon
    Molina, Claudia
    Mncube, Zenele
    Leslie, Alasdair
    Prado, Julia
    Chonco, Fundi
    Mphatshwe, Wendy
    Tudor-Williams, Gareth
    Jeena, Prakash
    Blanckenberg, Natasha
    Dong, Krista
    Kiepiela, Photini
    Coovadia, Hoosen
    Ndung'u, Thumbi
    Walker, Bruce D.
    Goulder, Philip J. R.
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 10234 - 10244
  • [9] Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease
    Calabrese, LH
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (06) : S87 - S93
  • [10] Otolaryngologic disease progression in children with human immunodeficiency virus infection
    Chen, AY
    Ohlms, LA
    Stewart, MG
    Kline, MW
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1996, 122 (12) : 1360 - 1363